尼沃卢马布治疗索拉费尼布失效后出现多重肺转移的晚期肝细胞癌
Jaewoong Kim1, Jin Won Chang1, Jun Yong Park1,2,3
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
晚期肝细胞癌 (HCC) 患者在经过过动脉化学栓塞和索拉费尼布的治疗中失败,获得了尼沃卢马布的完整反应. 这种免疫疗法为高级HCC提供了有前途的二线治疗选择.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 十多年来,索拉菲尼布一直是高级肝细胞癌 (HCC) 的标准一线全身治疗方法.
- 雷戈拉菲尼布是仅有的全球批准的第二线治疗治疗HCC后索拉菲尼布进展.
- 免疫疗法正在成为各种癌症的重要治疗方式,包括先进的HCC.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Treatment Resistant Cancers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
